CDER Announces Guidance Documents for 2018

News
Article

The FDA center released its list of planned guidance documents for the rest of the year.

FDA’s Center for Drug Evaluation and Research (CDER) released its planned 2018 agenda for guidance documents on Jan. 19, 2018. The center plans on publishing approximately 107 guidance documents this year discussing topics ranging from advertising, clinical, development, safety, approval submissions, generics, labeling, and more.

Specific topics to be addressed by CDER this year include biomarker qualification, postmarket safety reporting, electronic regulatory submissions, drug master files, CMC approval requirements, opioid products, rare diseases, and user fees.

The agency also has a variety of guidance documents addressing generic drugs and abbreviated new drug applications. Exclusivity, topical patches, and bioequivalence studies are some of the generic drug topics discussed.

The full list of planned guidance documents can be found on FDA’s website.

Source: FDA

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes